Keyword: Amyloid Beta

CEO Eliav Shaked shows the RetiSpec technology to an older adult — RetiSpec: A Novel Retina Scanner for Diagnosing Dementia
The RetiSpec retinal scanning device for clinical use may detect the presence of Alzheimer’s disease earlier and more cost-effectively than standard, expensive testing methods.

14 May, 2020 tagged I2P2 v3 / Cognitive Health / Alzheimer’s disease / Amyloid Beta / biomarkers / dementia / early detection / eye scanner / RetiSpec / Industry Innovation Partnership Program (I2P2)